Stem cell transplants
Executive Summary
FDA's Biological Response Modifiers Advisory Committee will meet July 13 and 14 to discuss development issues related to human stem cells as cellular replacement therapies for neurologic disorders. The meeting will begin at 8:30 a.m. at the Hilton in Gaithersburg, Md